Medications are prescribed to improve patients’ health, not worsen it; however, when medications have dangerous interactions or are taken incorrectly, patients can experience hazardous, eve
For so long the US healthcare system was built around the provider, with appointments and services set by the provider (along with insurance reimbursement systems).
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh